{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1383670320578445697.json","@type":"Researcher","foaf:Person":[{"foaf:name":[{"@value":"Melinda C. Myzak"}],"foaf:familyName":[{"@value":"Myzak"}],"foaf:givenName":[{"@value":"Melinda C."}]}],"product":[{"@id":"https://cir.nii.ac.jp/crid/1363670320578445696","@type":"Article","productIdentifier":[{"@type":"DOI","@value":"10.1093/carcin/bgi253"},{"@type":"URI","@value":"http://academic.oup.com/carcin/article-pdf/27/2/344/7512746/bgi253.pdf"},{"@type":"NAID","@value":"30018394358"}],"notation":[{"@value":"Dietary HDAC inhibitors: time to rethink weak ligands in cancer chemoprevention?"}],"relation":[{"type":"creator"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1093/carcin/bgi253_FTONFEBfupFKWutdiRE4OIFn5A7"}]}